Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Hair loss doesn't affect COVID-19 severity.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

Oral minoxidil improved hair loss more than oral dutasteride.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

Hair loss in young men in Central India is linked to severe heart disease.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

New grading scale accurately measures hair loss severity and treatment effectiveness.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Acne treatment varies by severity, using topical treatments for mild cases, combination therapies for moderate cases, and oral isotretinoin for severe cases, with hormonal treatments for some women.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

Pediatric hair loss requires personalized treatment based on cause and severity, with specialist support.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

AI can accurately measure hair loss severity in alopecia areata.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A keratin hHb6 mutation causes a hair disorder with varying severity, influenced by other factors.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.